Label Changes for:
Xalatan (latanoprost ophthalmic solution)
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- periorbital and lid changes resulting in deepening of the eyelid sulcus